Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Elanco Animal Health, 3D Systems: 5 Stock Gainers for Wednesday
By Rob Lenihan
Oct 7, 2020 4:27 PM EDT
PRESS RELEASES
Ocular Therapeutix™ Presents Interim Topline Data From The Phase 1 Clinical Trial Of OTX-TIC In Patients With Primary Open Angle Glaucoma Or Ocular Hypertension At The 10th Annual Glaucoma 360 New Horizons Forum
By Business Wire
Jan 20, 2021 8:00 AM EST
PRESS RELEASES
Ocular Therapeutix™ Promotes Michael Goldstein, MD, MBA, To President, Ophthalmology And Appoints Rabia Gurses Ozden, MD As Senior Vice President, Clinical Development
By Business Wire
Jan 7, 2021 8:00 AM EST
PRESS RELEASES
Ocular TherapeutixTM Announces Exercise Of Underwriters' Option To Purchase Additional Shares
By Business Wire
Dec 28, 2020 8:00 AM EST
PRESS RELEASES
Ocular Therapeutix™ Announces Submission To The FDA Of A Supplemental New Drug Application For DEXTENZA® (dexamethasone Ophthalmic Insert) For The Treatment Of Ocular Itching Associated With Allergic Conjunctivitis
By Business Wire
Dec 22, 2020 8:45 AM EST
PRESS RELEASES
Ocular TherapeutixTM Announces Pricing Of Public Offering Of Common Stock
By Business Wire
Dec 15, 2020 9:47 PM EST
PRESS RELEASES
Ocular Therapeutix™ Announces Proposed Public Offering Of Common Stock
By Business Wire
Dec 14, 2020 4:13 PM EST
PRESS RELEASES
Ocular Therapeutix™ To Present At The Piper Sandler 32nd Annual Virtual Healthcare Conference
By Business Wire
Nov 23, 2020 8:00 AM EST
PRESS RELEASES
Ocular Therapeutix™ To Present Data At The American Academy Of Ophthalmology (AAO) 2020 Virtual Annual Meeting
By Business Wire
Nov 11, 2020 9:00 AM EST
PRESS RELEASES
Ocular Therapeutix™ To Participate At Two Upcoming Investor Conferences
By Business Wire
Nov 9, 2020 4:01 PM EST
PRESS RELEASES
Ocular Therapeutix Announces Receipt Of A Permanent Category I CPT Code From The American Medical Association For The Insertion Of Intracanalicular Inserts
By Business Wire
Nov 4, 2020 8:00 AM EST
PRESS RELEASES
Ocular Therapeutix™ And AffaMed Therapeutics Announce License Agreement And Collaboration For DEXTENZA® And OTX-TIC In Asia
By Business Wire
Oct 30, 2020 8:00 AM EDT
PRESS RELEASES
Ocular Therapeutix™ To Report Third Quarter 2020 Financial Results
By Business Wire
Oct 23, 2020 7:00 AM EDT
PRESS RELEASES
Ocular Therapeutix™ Announces Pricing Of Public Offering Of Common Stock
By Business Wire
Oct 14, 2020 6:30 AM EDT
PRESS RELEASES
Ocular Therapeutix™ Announces Proposed Public Offering Of Common Stock
By Business Wire
Oct 13, 2020 5:01 PM EDT
INVESTING
Elanco Animal Health, 3D Systems: 5 Stock Gainers for Wednesday
By Rob Lenihan
Oct 7, 2020 4:27 PM EDT
PRESS RELEASES
Ocular Therapeutix™ Announces First Patients Dosed In Phase 2 Clinical Trial Of OTX-CSI For The Treatment Of Dry Eye Disease
By Business Wire
Sep 29, 2020 8:00 AM EDT
PRESS RELEASES
Ocular Therapeutix™ Announces First Patient Dosed In Phase 3 Clinical Trial Of DEXTENZA® For The Treatment Of Post-Surgical Ocular Inflammation And Pain In Children
By Business Wire
Sep 10, 2020 7:00 AM EDT
PRESS RELEASES
Ocular Therapeutix™ Announces Successful Resolution Of FDA Warning Letter Related To ReSure® Sealant
By Business Wire
Sep 8, 2020 7:00 AM EDT
PRESS RELEASES
(Graphic: Business Wire)
By Business Wire
Sep 4, 2020 7:00 AM EDT
PRESS RELEASES
Ocular Therapeutix™ To Present At Two Upcoming Investor Conferences
By Business Wire
Sep 3, 2020 7:00 AM EDT
PRESS RELEASES
Ocular Therapeutix™ To Report Second Quarter 2020 Financial Results
By Business Wire
Jul 31, 2020 7:00 AM EDT
PRESS RELEASES
Ocular Therapeutix Announces Second Medicare Administrative Contractor To Establish New Published Physician Fee Schedule For Administration Of Intracanalicular Inserts
By Business Wire
Jul 23, 2020 7:00 AM EDT
PRESS RELEASES
Ocular Therapeutix Presents At The 12th Annual Ophthalmology Innovation Summit (OIS)
By Business Wire
Jul 17, 2020 7:30 AM EDT
PRESS RELEASES
Ocular Therapeutix™ To Present Data At The Association For Research In Vision And Ophthalmology (ARVO) Annual Meeting
By Business Wire
Jun 15, 2020 8:00 AM EDT